GPI attending the World EPA Congress

21-23 March 2023, Amsterdam RAI, Amsterdam

GPI will be attending the World EPA congress, held in Amsterdam RAI, on 21-23 March 2023. GPI will be on stand 15, and our representatives will be on hand to discuss how GPI can optimise your pricing and market access decision-making in 2022, 2023 and beyond. In addition we will be contributing to the conference program, discussing our innovative research on orphan drugs – utilising the only value assessment and price prediction platform on the market. Details below!

World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, multiple streams and over 1200 attendees from pharma, biotech and Payers/HTA’s.

Visit our stand

Come and visit our stand (15) to find out about THE ONLY value assessment and price prediction platform on the market! We will be providing demonstrations and discussing the platform, in addition to showcasing how the horizon methodology can minimise the risk of your drug launch, reduce time-intensive payer research and maximise commercial success.

In addition, find out how we utilise data from GPI pulse™ for value, price, and market access insights – with a live demos. Our GPI pulse™ product manager Margaret Labban will be at the conference to discuss and demonstrate how GPI pulse™ can help create more efficient, evidence-led market access strategies.

You will also be able to discuss pricing and market access challenges, stakeholder relationships discover innovative tools and solutions for the ecosystem. Most notably, GPI’s innovative suite of technological and service-based solutions, GPI pulse™ data analytics platform, and our unique platform solution, based on our award-winning methodology that quantifies an asset’s position in the market.


Wednesday 22 March (Day 2) – 3:15pm

Track: Rare Diseases

Presenter: Preeti Patel, GPI CEO & Founder

Title: Keeping up with rapid innovation: how technology is solving the orphan drugs pricing problem

EPA congress

Share the Article:

Sign up to our mailing list to be informed of the latest webinars